It has been an ugly day for the markets in the past few days. The biotech sector has been particularly hard hit.
In light of an upcoming earnings results and a disappointing data readout, analysts weigh in on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Chimerix …
Wall Street analysts are weighing in on biopharmaceutical company Chimerix Inc (NASDAQ:CMRX) and hardwood-flooring maker Lumber Liquidators Holdings Inc (NYSE:LL), as shares of both companies fell sharply …
Chimerix Inc (NASDAQ:CMRX) is up 5% in pre-market trading following news that Point 72 Asset Management showed a 5.3% stake in the company …
Fitbit Inc (NYSE:FIT) is up 6% in pre-market trading this morning following Christmas Day’s news that its app made it to the top …
2014 has been an eventful year on Wall Street. Now that the year is coming to an end, what stocks should investors be …
In a research report issued today, William Blair analyst Y. Katherine Xu maintained an Outperform rating on Chimerix (NASDAQ:CMRX) with a price target of …
In a research report issued today, Brean Capital analyst Jonathan Aschoff assigned a Buy rating on Chimerix (NASDAQ:CMRX) with a price target of …
In a research report released today, Brean Capital analyst Jonathan Aschoff maintained a Buy rating on Chimerix (NASDAQ:CMRX) with a $33 price target, as preliminary data from …
In a research report issued today, Brean Capital analyst Jonathan Aschoff maintained a Buy rating on Chimerix (NASDAQ:CMRX) with a price target of …
